Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization via Inhibition of VEGF Production

Neovascularization (NV) of the cornea disrupts vision which leads to blindness. Investigation of antiangiogenic, slow-release and biocompatible approaches for treating corneal NV is of great importance. We designed an eye drop formulation containing gelatin/epigallocatechin-3-gallate (EGCG) nanopart...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyagawa, Takuya, Chen, Zhi-Yu, Chang, Che-Yi, Chen, Ko-Hua, Wang, Yang-Kao, Liu, Guei-Sheung, Tseng, Ching-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284559/
https://www.ncbi.nlm.nih.gov/pubmed/32354067
http://dx.doi.org/10.3390/pharmaceutics12050404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284559/
https://www.ncbi.nlm.nih.gov/pubmed/32354067
http://dx.doi.org/10.3390/pharmaceutics12050404

Ejemplares similares